Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2002
10/09/2002EP0996622B1 Novel spiroazabicyclic heterocyclic compounds
10/09/2002EP0754189B1 Receptor modulating agents and methods relating thereto
10/09/2002CN1373771A Vaccine
10/09/2002CN1373763A Pteridinones and kinase inhibitors
10/09/2002CN1373760A Quinuclidine derivs. as muscarinic M3 receptors ligand and their use
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1373201A Health-care Yikang liquor
10/09/2002CN1373199A Process for preparing health-care arborvitae seed-schisandra fruit liquor
10/09/2002CN1373198A Process for preparing health-care hedgehog hydnum-ophiopogon root liquor
10/09/2002CN1373197A Process for preparing health-care arborvitae seed-agastache liquor
10/09/2002CN1373196A Process for preparing health-care cloves-eucommia bark liquor
10/09/2002CN1373195A Process for preparing health-care chaenomeles fruit-liquorice root liquor
10/09/2002CN1373194A Process for preparing health-care tendrilled fritillary bulb-gastrodia tuber liquor
10/09/2002CN1373193A Process for preparing health-care arborvitae seed-Chinese angelica root liquor
10/09/2002CN1373192A Process for preparing health-care agastache-ganoderma liquor
10/09/2002CN1373191A Process for preparing health-care chian-xiong rhizome cinnamon bark liquor
10/09/2002CN1373190A Process for preapring health-care lily bulb-dried ginger liquor
10/09/2002CN1373189A Process for preparing health-care honeysuckle flower-white atracylodes rhizome liquor
10/09/2002CN1373188A Process for preparing health-care Momordicae fruit-wolfberry fruit liquor
10/09/2002CN1373187A Process for preparing healht-care amomum fruit-red jujube liquor
10/09/2002CN1373186A Process for preparing health-care bupleurum root-eucommia bark liquor
10/09/2002CN1373185A Process for preparing health-care black plum-ophiopogon root liquor
10/09/2002CN1373184A Process for preparing health-care eagle wood-lily bulb liquor
10/09/2002CN1373183A Process for preparing health-care chaenomeles fruit-red jujube liquor
10/09/2002CN1373182A Process for preparing health-care black plum-apricot kernel liquor
10/09/2002CN1373127A Crystal choline ascorbate
10/09/2002CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002CN1372972A Medicine for nourishing kidney
10/09/2002CN1372962A Medical liquor
10/09/2002CN1372958A Prescription of liquid medicine for invigorating function of stomach, protecting liver and sobering up
10/09/2002CN1372953A Capsule for treating hepatism
10/09/2002CN1372944A Medicine for treating viral hepatitis and its preparing process
10/09/2002CN1372933A Application of N-acetyl-D-aminoglucose in preparing medicine to prevent and treat motion sickness
10/09/2002CN1372932A Application of N-acetyl-D-aminoglucose in preparing medicine to help treatment of perianal diseases
10/09/2002CN1372842A Formulation of 'Jianpi Hewei' jelly
10/09/2002CN1092065C Medicine for cleaning intestinal canal and preparing process thereof
10/09/2002CN1092057C 'Yuganwan' pill for treating hepatitis
10/08/2002US6462086 Non-malignant disease treatment with Ras antagonists
10/08/2002US6462070 Photosensitizer conjugates for pathogen targeting
10/08/2002US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome
10/08/2002US6462063 N,n'-disubstituted hydantoin hydroxamates; regulating, modulating and/or inhibiting abnormal collagen formation to treat fibrotic disorders; hepatic cirrhosis, arthritis
10/08/2002US6462058 Benzimidazole compound crystal
10/08/2002US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
10/08/2002US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/08/2002US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002US6462035 Binding to neuronal nicotinic acetylcholine specific receptor; modulating cholinergic function; reducing nicotine addiction; inflammatory and irritable bowel syndrome, spastic dystonia, chronic and acute pain, eating disorders
10/08/2002US6462019 Inhibitors of proteasomal activity and production for stimulating bone growth
10/08/2002US6462017 Method of reducing side effects of chemotherapy in cancer patients
10/08/2002US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis
10/08/2002US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/08/2002US6461646 Pharmaceutical composition for preventing and/or curing digestive disorders
10/08/2002US6461642 Crystallization using supercritical or subcritical fluids
10/08/2002US6461625 Nanoemulsion based on alkoxylated alkenyl succinates or alkoxylated alkenyl succinates of glucose and its uses in the cosmetics, dermatological, opthalmological and/or pharmaceutical fields
10/08/2002US6461607 Probiotic, lactic acid-producing bacteria and uses thereof
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/08/2002CA2066083C Benzodiazepine analogs as cholecystokinin antagonists
10/08/2002CA2037092C Bile acid unsaturated derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
10/04/2002CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002WO2002077239A1 Hcv-binding polypeptides
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/03/2002WO2002077174A2 Human cytokine receptor
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076989A1 Protein phosphate inhibitors
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076983A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076949A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002WO2002076504A1 Remedies for inflammatory bowel diseases
10/03/2002WO2002076478A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids
10/03/2002WO2002076472A2 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
10/03/2002WO2002076471A1 Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
10/03/2002WO2002076468A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
10/03/2002WO2002076456A1 Method for inhibiting apoptosis of stem cells
10/03/2002WO2002076454A1 Method for treatment of cancer and compositions for use therein
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076445A1 Agents against stress-induced diseases drugs
10/03/2002WO2002076435A2 Lipid profile modulation with steroids
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002076400A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002062944A3 Novel physiologically active peptide and use thereof
10/03/2002WO2002062794A3 Compounds
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 1258